STAT News · Scour

STAT+: AI could check millions of CT scans for heart risk. Who will pay for it?

statnews.com·4w

Opinion: Hosting the ‘intellectual wrestling match’ between MAHA, public health

statnews.com·4w

Flawed study on the antidepressant Paxil came with a cautionary note — if you knew how to find it

statnews.com·4w

STAT+: Congress returns to a packed health care agenda

statnews.com·4w

STAT+: FDA pressures drugmakers to report trial results

statnews.com·4w

STAT+: Hospitals offer chatbots to fight off ChatGPT

statnews.com·4w

STAT+: Pharmalittle: We’re reading about an FDA push for trial transparency, a Novo-OpenAI deal, and more

statnews.com·4w

A fluoride shortage for some U.S. water systems

statnews.com·4w

STAT+: Dana-Farber CEO talks untangling from Mass General Brigham and building new cancer hospital

statnews.com·4w

Opinion: My brother can’t access a just-approved breakthrough drug for his rare disease

statnews.com·4w

For Ben Sasse, Revolution Medicines’ pancreatic cancer trial felt like his best, only option

statnews.com·4w

A top WHO official confronts Iran war fallout, and weighs bid for an even bigger role

statnews.com·4w

STAT+: Maryland state affordability board sets its first price cap for a medicine

statnews.com·4w

STAT+: FDA pushes drugmakers to report missing clinical trial results

statnews.com·4w

STAT+: Federal judge tosses California No Surprises Act lawsuit against HaloMD

statnews.com·4w

STAT+: Access granted: CMS greenlights more than 150 participants for chronic care experiment

statnews.com·4w

STAT+: Trump goes soft on insurance, and a medical underwriting chart

statnews.com·4w

STAT+: GSK advancing ovarian cancer drug mo-rez

statnews.com·4w

On positioning nurses as health experts

statnews.com·4w

STAT+: Pharmalittle: We’re reading about a pancreatic cancer pill, FDA rejecting a Replimune drug again, and more

statnews.com·4w

Log in to enable infinite scrolling